Category: Corona Virus Vaccine

Page 3«..2345..1020..»

When will COVID-19 vaccines be available in California for fall/winter surge? – VC Star

August 27, 2024

vcstar.com wants to ensure the best experience for all of our readers, so we built our site to take advantage of the latest technology, making it faster and easier to use.

Unfortunately, your browser is not supported. Please download one of these browsers for the best experience on vcstar.com

Link:

When will COVID-19 vaccines be available in California for fall/winter surge? - VC Star

FDA approves updated COVID-19 booster shots, health officials urge Marylanders to get vaccinated – CBS News

August 27, 2024

BALTIMORE -- On Thursday the FDA approved updated COVID-19 booster shots from Moderna and Pfizer that would target the KP.2 strain of the coronavirus. Officials say KP.2 has spread rapidly these past few months, highlighting the warning as we head into fall and its respiratory hotbed.

"The virus is changing but also the infections that we get from past infections or past vaccines, wanes over time," Dr. Mandy Cohen, Director of the Center for Disease Control and Prevention said.

"Last fall and winter, 10% of the U.S. population had the flu at the peak of the respiratory illness season, more than 2500 people a week were dying from COVID-19," Jeff Nesbit, Assistant Secretary for Public Affairs at the U.S. Health & Human Services said.

Health officials especially want older Marylanders and those who are immunocompromised to make sure they get the updated annual booster, the flu shot, and the RSV vaccine to avoid a trip to the emergency room.

"We're talking about a vaccine that is continuing to evolve and it is likely that what's going to be there four or five months from now, will further evolve from where it is now," Dr. Peter Marks of the Food and Drug Administration said.

"So, you want to make sure you're getting the highest level of protection you possibly can going into [the] season where we know we will see more of the COVID virus circulating, the flu virus circulating," Cohen said.

Now that the updated booster has been approved, Moderna and Pfizer have already started shipping the latest vaccine. Officials are encouraging those most vulnerable to get it as soon as possible, while others can wait until October to maximize protection.

However, their message is to just get it done to protect yourself and others.

"Even though COVID is not the flu, being able to get that shot in the arm is what we really need to have happen, that's the point of this campaign here," Marks explained.

The Biden Administration announced that starting in late September four free COVID tests will be mailed to Americans, a one-two punch to keep people safe as we head into respiratory illness season.

See the rest here:

FDA approves updated COVID-19 booster shots, health officials urge Marylanders to get vaccinated - CBS News

CDC: COVID-19 surging across the U.S. | AHA News – American Hospital Association

August 27, 2024

The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been since January 2022. Wastewater surveillance, an early warning sign of COVID-19s spread in communities, demonstrates very high viral activity for COVID-19 across the U.S. indicating positivity rates could be even higher than reported test results. CDC recommends that everyone ages six months and older receive a 2024-2025 COVID-19 vaccine.

In advance of the respiratory virus season, the Department of Health and Human Services Aug. 19 launched a new public education campaign on common respiratory viruses and available vaccines including flu, COVID-19 and respiratory syncytial virus (commonly known as RSV).

Read more:

CDC: COVID-19 surging across the U.S. | AHA News - American Hospital Association

Feds announce new round of free COVID tests – University of Minnesota Twin Cities

August 27, 2024

Though the United States may be past the peak of its latest COVID-19 surge, federal health officials are eying ways to reduce the spread of the virus over colder months and the holiday season, including a relaunch of free COVID tests by mail.

The announcement comes as health providers gear up immunization activities ahead of the main respiratory virus season. Officials from federal agencies shared their outlooks for the upcoming season, along with the status on the tools to prevent them, at a media briefing today.

Dawn O'Connell, JD, assistant secretary for preparedness and response at the Department of Health and Human Services, said that, starting in September, people can order four free COVID tests to be delivered through the mail.

This is the seventh round of free tests since 2021, and the mail delivery program, combined with year-round access at outlets such as community clinics, has so far delivered nearly 1.8 million tests.

They do no good sitting in medicine cabinets.

She urged people to order the tests as families move indoors as the weather cools and as people prepare for travel and the holidays. O'Connell also urged people to use them. "They do no good sitting in medicine cabinets."

CDC Director Mandy Cohen, MD, MPH, said the CDC's forecasting for the fall and winter suggests similar or lower numbers of peak hospitalizations for all three of the main respiratory illnesses: COVID, flu, and respiratory syncytial virus (RSV) infection.

She included a caveat, however, that assumptions could change, based on changes in SARS-CoV-2, the virus that causes COVID-19, which evolves faster than flu, and other factors.

At today's briefing, health officials fielded questions about COVID vaccine access to lower-income and uninsured people, as well as regarding who should be vaccinated, especially given the current level of high activity.

The federal government's bridge access program, launched last September to provide broad COVID vaccine access to millions of uninsured Americans, has now ended due to budget recissions. But at today's briefing, Cohen announced that the CDC has identified $62 million in funding for state and local health departments to obtain the vaccine.

She also added that free access to the antiviral drug Paxlovid through an assistance program run by Pfizer is available until the end of 2024 and that both Pfizer and Merck have assistance programs for uninsured and underinsured people.

When asked about the timing of updated vaccines, for which approval came yesterday for the two mRNA vaccines, Peter Marks, MD, who directs the Food and Drug Administration's Center for Biologics Evaluation and Research, said officials are always looking for concerning mutations and whether a vaccine update is urgently needed. However, he said the main consideration currently is getting doses into patient's arms, and that fall vaccination drives are the most realistic way to ensure that many people are vaccinated and boost their immunity to the virus.

The only way to get long COVID is having COVID.

Health officials said COVID is still more dangerous than flu, and Marks emphasized that the vaccine's impact against getting COVID is also a way to prevent long COVID. "The only way to get long COVID is having COVID," he said.

For respiratory viruses as a whole, activity is still low, but wastewater levels for COVID are still at the very high level, the CDC said today in its latest data updates. Levels are still highest in the West, which continues to show a declining trend. The South and Midwest are also showing downward trends.

The latest data from WastwaterSCAN, a national wastewater monitoring system based at Stanford University in partnership with Emory University, shows that SARS-CoV-2 detections remain high in all regions, but with a downward trend over the past 3 weeks nationally and in the Northeast, South, and West.

Meanwhile, test positivity for COVID was at 18% nationally, the same as the previous week, with the highest levels in Texas and surrounding states. Emergency department visits for COVID were down a bit, and deaths remained level.

Go here to see the original:

Feds announce new round of free COVID tests - University of Minnesota Twin Cities

When will COVID-19 vaccines be available for fall-winter season? What to know amid surge – Tennessean

August 27, 2024

tennessean.com wants to ensure the best experience for all of our readers, so we built our site to take advantage of the latest technology, making it faster and easier to use.

Unfortunately, your browser is not supported. Please download one of these browsers for the best experience on tennessean.com

Read the rest here:

When will COVID-19 vaccines be available for fall-winter season? What to know amid surge - Tennessean

Health board member excluded from executive session after COVID-19 vaccine liability warning – wenatcheeworld.com

August 27, 2024

State Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington Washington D.C. West Virginia Wisconsin Wyoming Puerto Rico US Virgin Islands Armed Forces Americas Armed Forces Pacific Armed Forces Europe Northern Mariana Islands Marshall Islands American Samoa Federated States of Micronesia Guam Palau Alberta, Canada British Columbia, Canada Manitoba, Canada New Brunswick, Canada Newfoundland, Canada Nova Scotia, Canada Northwest Territories, Canada Nunavut, Canada Ontario, Canada Prince Edward Island, Canada Quebec, Canada Saskatchewan, Canada Yukon Territory, Canada

Zip Code

Country United States of America US Virgin Islands United States Minor Outlying Islands Canada Mexico, United Mexican States Bahamas, Commonwealth of the Cuba, Republic of Dominican Republic Haiti, Republic of Jamaica Afghanistan Albania, People's Socialist Republic of Algeria, People's Democratic Republic of American Samoa Andorra, Principality of Angola, Republic of Anguilla Antarctica (the territory South of 60 deg S) Antigua and Barbuda Argentina, Argentine Republic Armenia Aruba Australia, Commonwealth of Austria, Republic of Azerbaijan, Republic of Bahrain, Kingdom of Bangladesh, People's Republic of Barbados Belarus Belgium, Kingdom of Belize Benin, People's Republic of Bermuda Bhutan, Kingdom of Bolivia, Republic of Bosnia and Herzegovina Botswana, Republic of Bouvet Island (Bouvetoya) Brazil, Federative Republic of British Indian Ocean Territory (Chagos Archipelago) British Virgin Islands Brunei Darussalam Bulgaria, People's Republic of Burkina Faso Burundi, Republic of Cambodia, Kingdom of Cameroon, United Republic of Cape Verde, Republic of Cayman Islands Central African Republic Chad, Republic of Chile, Republic of China, People's Republic of Christmas Island Cocos (Keeling) Islands Colombia, Republic of Comoros, Union of the Congo, Democratic Republic of Congo, People's Republic of Cook Islands Costa Rica, Republic of Cote D'Ivoire, Ivory Coast, Republic of the Cyprus, Republic of Czech Republic Denmark, Kingdom of Djibouti, Republic of Dominica, Commonwealth of Ecuador, Republic of Egypt, Arab Republic of El Salvador, Republic of Equatorial Guinea, Republic of Eritrea Estonia Ethiopia Faeroe Islands Falkland Islands (Malvinas) Fiji, Republic of the Fiji Islands Finland, Republic of France, French Republic French Guiana French Polynesia French Southern Territories Gabon, Gabonese Republic Gambia, Republic of the Georgia Germany Ghana, Republic of Gibraltar Greece, Hellenic Republic Greenland Grenada Guadaloupe Guam Guatemala, Republic of Guinea, Revolutionary People's Rep'c of Guinea-Bissau, Republic of Guyana, Republic of Heard and McDonald Islands Holy See (Vatican City State) Honduras, Republic of Hong Kong, Special Administrative Region of China Hrvatska (Croatia) Hungary, Hungarian People's Republic Iceland, Republic of India, Republic of Indonesia, Republic of Iran, Islamic Republic of Iraq, Republic of Ireland Israel, State of Italy, Italian Republic Japan Jordan, Hashemite Kingdom of Kazakhstan, Republic of Kenya, Republic of Kiribati, Republic of Korea, Democratic People's Republic of Korea, Republic of Kuwait, State of Kyrgyz Republic Lao People's Democratic Republic Latvia Lebanon, Lebanese Republic Lesotho, Kingdom of Liberia, Republic of Libyan Arab Jamahiriya Liechtenstein, Principality of Lithuania Luxembourg, Grand Duchy of Macao, Special Administrative Region of China Macedonia, the former Yugoslav Republic of Madagascar, Republic of Malawi, Republic of Malaysia Maldives, Republic of Mali, Republic of Malta, Republic of Marshall Islands Martinique Mauritania, Islamic Republic of Mauritius Mayotte Micronesia, Federated States of Moldova, Republic of Monaco, Principality of Mongolia, Mongolian People's Republic Montserrat Morocco, Kingdom of Mozambique, People's Republic of Myanmar Namibia Nauru, Republic of Nepal, Kingdom of Netherlands Antilles Netherlands, Kingdom of the New Caledonia New Zealand Nicaragua, Republic of Niger, Republic of the Nigeria, Federal Republic of Niue, Republic of Norfolk Island Northern Mariana Islands Norway, Kingdom of Oman, Sultanate of Pakistan, Islamic Republic of Palau Palestinian Territory, Occupied Panama, Republic of Papua New Guinea Paraguay, Republic of Peru, Republic of Philippines, Republic of the Pitcairn Island Poland, Polish People's Republic Portugal, Portuguese Republic Puerto Rico Qatar, State of Reunion Romania, Socialist Republic of Russian Federation Rwanda, Rwandese Republic Samoa, Independent State of San Marino, Republic of Sao Tome and Principe, Democratic Republic of Saudi Arabia, Kingdom of Senegal, Republic of Serbia and Montenegro Seychelles, Republic of Sierra Leone, Republic of Singapore, Republic of Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia, Somali Republic South Africa, Republic of South Georgia and the South Sandwich Islands Spain, Spanish State Sri Lanka, Democratic Socialist Republic of St. Helena St. Kitts and Nevis St. Lucia St. Pierre and Miquelon St. Vincent and the Grenadines Sudan, Democratic Republic of the Suriname, Republic of Svalbard & Jan Mayen Islands Swaziland, Kingdom of Sweden, Kingdom of Switzerland, Swiss Confederation Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand, Kingdom of Timor-Leste, Democratic Republic of Togo, Togolese Republic Tokelau (Tokelau Islands) Tonga, Kingdom of Trinidad and Tobago, Republic of Tunisia, Republic of Turkey, Republic of Turkmenistan Turks and Caicos Islands Tuvalu Uganda, Republic of Ukraine United Arab Emirates United Kingdom of Great Britain & N. Ireland Uruguay, Eastern Republic of Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Viet Nam, Socialist Republic of Wallis and Futuna Islands Western Sahara Yemen Zambia, Republic of Zimbabwe

Read the original post:

Health board member excluded from executive session after COVID-19 vaccine liability warning - wenatcheeworld.com

Health leaders expect new COVID-19 vaccines to be available in Oregon in coming weeks – KGW.com

August 27, 2024

The updated mRNA vaccines target a strain called KP.2, which is circulating now and is expected to ramp up in the fall and winter months.

PORTLAND, Ore. On Thursday, the Food and Drug Administration (FDA) approved two new COVID-19 vaccines one from Moderna and one from Pfizer marking the third time the vaccines have been updated to keep up with new strains of the virus.

Leaders with the Oregon Health Authority (OHA) said the approval, which came earlier than last year, was not unexpected. The mRNA vaccines target a strain called KP.2, which is circulating now and is expected to ramp up in the fall and winter months. OHA couldn't give an exact timeline of when Oregonians would be able to get the updated vaccines, but did say they'd be available in the coming weeks.

"I think for people that are on the fence and say, 'Oh, a new FDA vaccine, I'm going to wait,' this is the same vaccine that we have been using for the past several years," said Dr. Dean Sidelinger, OHA's health officer and state epidemiologist. "It is updated to fight some of the more recent variants, but the technology, the proven science behind this vaccine, has been with us for several years."

Health officials stress the protection they'll offer, especially against severe disease.

"Certainly it's much safer and much less miserable to get a COVID vaccine than it is to have to recover from COVID to get that protection," Sidelinger said, "Because even those people who aren't in the hospital, if you recently have it, you know, have reported a lot of brain fog and really bad fatigue."

Sidelinger explained that those most at risk should get the shots sooner, including older adults, younger children and people who are immunocompromised.

"But all of us, you know, six months and older should consider getting this vaccine. The protection starts within weeks after getting the vaccine, so if you're someone who's at higher risk with COVID still circulating at fairly high levels, now it will offer you protection from the summer wave," Sidelinger said.

See original here:

Health leaders expect new COVID-19 vaccines to be available in Oregon in coming weeks - KGW.com

New COVID-19 booster shots have been approved. When should you get one? – Science News Magazine

August 27, 2024

Meghan Rosen is a staff writer who reports on the life sciences for Science News. She earned a Ph.D. in biochemistry and molecular biology with an emphasis in biotechnology from the University of California, Davis, and later graduated from the science communication program at UC Santa Cruz.

See the original post:

New COVID-19 booster shots have been approved. When should you get one? - Science News Magazine

Updated COVID shots from Pfizer, Moderna cleared by FDA – BioPharma Dive

August 27, 2024

Dive Brief:

So far, the FDA has been following a model akin to its practice for influenza vaccines, convening experts in the spring and summer to discuss the best strain for manufacturers to design their shots against.

Initially, the agency favored redesigning COVID vaccines to match the JN.1 variant broadly. It later specified that developers should focus on KP.2 specifically, if possible. The KP.2-targeting shots are expected to produce immune responses that also provide protective benefits against other strains within the JN.1 lineage.

The FDAs approval comes just ahead of the fall and winter seasons, when COVID cases and hospitalizations are expected to climb.

Given waning immunity of the population from previous exposure to the virus and from prior vaccination, we strongly encourage those who are eligible to consider receiving an updated COVID-19 vaccine to provide better protection against currently circulating variants, said Peter Marks, head of the FDA office that reviews vaccines, in a statement.

Pfizer and partner BioNTech said shipping of their reformulated vaccine will begin immediately and that doses will be available in the coming days.Moderna said its shot will be available in pharmacies and clinics in the same time frame.

The companies are using similar processes to manufacture their updated vaccines as they did with prior versions. Their approvals were based on the FDAs review of manufacturing data and nonclinical study results designed to show the shots are effective and safe. Side effects, such as injection site pain and headaches, are anticipated to be like previous boosters.

These updated vaccines meet the agencys rigorous, scientific standards for safety, effectiveness, and manufacturing quality, Marks said.

Novavax has also developed an updated version of its COVID vaccine which, unlike Pfizers and Modernas mRNA shots, is protein-based. The company has also submitted an application for authorization to the agency.

In June, the Centers for Disease Control and Prevention recommended that everyone aged 6 months and older receive an updated COVID vaccine when they are available.

While COVID vaccine uptake could rise this fall, both Pfizer and Moderna have in recent quarters reported steadily declining revenues from their vaccines. As a results, investors have turned their attention toward combination shots the companies are developing, as well as vaccines for respiratory syncytial virus.

See original here:

Updated COVID shots from Pfizer, Moderna cleared by FDA - BioPharma Dive

Page 3«..2345..1020..»